• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉内压力变化是否有助于通过痉挛激发试验诊断冠状动脉痉挛?

Do changes in intracoronary pressure aid coronary spasm diagnosis using the spasm provocation test?

作者信息

Teragawa Hiroki, Oshita Chikage, Uchimura Yuko

机构信息

Department of Cardiovascular Medicine, JR Hiroshima Hospital, Hiroshima 732-0057, Japan.

出版信息

World J Cardiol. 2024 Jan 26;16(1):16-26. doi: 10.4330/wjc.v16.i1.16.

DOI:10.4330/wjc.v16.i1.16
PMID:38313387
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10835468/
Abstract

BACKGROUND

Although the spasm provocation test (SPT) can diagnose coronary spasms, it would be helpful if it could also predict their occurrence.

AIM

To investigate whether coronary spasms can be predicted using changes in intracoronary artery pressure measured using a pressure wire during the SPT.

METHODS

Seventy patients underwent SPTs with pressure-wire measurement of intracoronary artery pressure. During each SPT, the pressure wire was advanced into the distal portion of the right coronary artery (RCA) and left anterior descending coronary artery, and the ratio of intracoronary pressure to aortic pressure (Pd/Pa) was monitored. Coronary spasm was defined as an arterial narrowing of > 90% in response to the administration of acetylcholine (ACh), with chest symptoms and/or ischemic electrocardiographic changes. ACh was administered to the RCA at low, moderate, or high doses of 20, 50, or 80 µg, respectively, and to the left coronary artery (LCA) at low, moderate, or high doses of 50, 100, or 200 µg, respectively. Coronary arteries with coronary spasms at low doses of ACh were defined as group L, and those with coronary spasms at moderate or high doses were defined as group MH. Those who did not occur coronary spasms at any ACh dose were designated as group N.

RESULTS

Among the 132 coronary arteries assessed using a pressure wire, there were 49 in group N, 25 in group L, and 58 in group MH. Baseline Pd/Pa was the lowest in group L ( = 0.001). The decrease in the Pd/Pa between baseline to low doses of ACh was lower in group MH than in group N ( < 0.001). A receiver-operating characteristics analysis showed that the cutoff baseline Pd/Pa value for predicting group L was 0.95, with a sensitivity of 0.600 (15/25) and a specificity of 0.713 (76/107) and that the cutoff value of Pd/Pa from baseline to low doses of ACh for predicting group MH was -0.04, with a sensitivity of 0.741 (43/58) and a specificity of 0.694 (34/49).

CONCLUSION

These findings suggest that indices of intracoronary pressure during SPT may be useful means for predicting the occurrence of coronary spasms.

摘要

背景

尽管痉挛激发试验(SPT)可诊断冠状动脉痉挛,但如果它还能预测其发生情况则会很有帮助。

目的

研究在SPT期间使用压力导丝测量冠状动脉内压力的变化能否预测冠状动脉痉挛。

方法

70例患者接受了SPT并通过压力导丝测量冠状动脉内压力。在每次SPT期间,将压力导丝推进到右冠状动脉(RCA)和左前降支冠状动脉的远端,并监测冠状动脉内压力与主动脉压力之比(Pd/Pa)。冠状动脉痉挛定义为在给予乙酰胆碱(ACh)后动脉狭窄>90%,伴有胸部症状和/或缺血性心电图改变。分别以20、50或80μg的低、中、高剂量向RCA给予ACh,以50、100或200μg的低、中、高剂量向左冠状动脉(LCA)给予ACh。在低剂量ACh时发生冠状动脉痉挛的冠状动脉定义为L组,在中剂量或高剂量时发生冠状动脉痉挛的冠状动脉定义为MH组。在任何ACh剂量下均未发生冠状动脉痉挛的患者被指定为N组。

结果

在使用压力导丝评估的132条冠状动脉中,N组有49条,L组有25条,MH组有58条。L组的基线Pd/Pa最低(=0.001)。MH组从基线到低剂量ACh时Pd/Pa的下降低于N组(<0.001)。受试者操作特征分析表明,预测L组的截止基线Pd/Pa值为0.95,敏感性为0.600(15/25),特异性为0.713(76/107);预测MH组从基线到低剂量ACh时Pd/Pa的截止值为-0.04,敏感性为0.741(43/58),特异性为0.694(34/49)。

结论

这些发现表明,SPT期间冠状动脉内压力指标可能是预测冠状动脉痉挛发生的有用手段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d69c/10835468/9100259a5b84/WJC-16-16-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d69c/10835468/c6ee17daa08c/WJC-16-16-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d69c/10835468/293aef7f85c5/WJC-16-16-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d69c/10835468/e4927a224e72/WJC-16-16-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d69c/10835468/9100259a5b84/WJC-16-16-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d69c/10835468/c6ee17daa08c/WJC-16-16-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d69c/10835468/293aef7f85c5/WJC-16-16-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d69c/10835468/e4927a224e72/WJC-16-16-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d69c/10835468/9100259a5b84/WJC-16-16-g004.jpg

相似文献

1
Do changes in intracoronary pressure aid coronary spasm diagnosis using the spasm provocation test?冠状动脉内压力变化是否有助于通过痉挛激发试验诊断冠状动脉痉挛?
World J Cardiol. 2024 Jan 26;16(1):16-26. doi: 10.4330/wjc.v16.i1.16.
2
Does the intracoronary pressure differ according to two types (diffuse or focal) of coronary spasm?冠状动脉内压力在冠状动脉痉挛的两种类型(弥漫性或局灶性)之间是否存在差异?
World J Cardiol. 2023 Jan 26;15(1):1-12. doi: 10.4330/wjc.v15.i1.1.
3
Induction of coronary artery spasm by two pharmacological agents: comparison between intracoronary injection of acetylcholine and ergonovine.两种药理药物诱发冠状动脉痉挛:冠状动脉内注射乙酰胆碱与麦角新碱的比较
Coron Artery Dis. 2003 Sep;14(6):451-7. doi: 10.1097/00019501-200309000-00006.
4
Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations.选择性痉挛激发试验的临床影响:1508例检查中乙酰胆碱与麦角新碱的比较
Coron Artery Dis. 2004 Dec;15(8):491-7. doi: 10.1097/00019501-200412000-00006.
5
Feasibility of omitting provocation test with 50 μg of acetylcholine in left coronary artery.省略左冠状动脉内50μg乙酰胆碱激发试验的可行性。
Heart Vessels. 2017 Jun;32(6):685-689. doi: 10.1007/s00380-016-0926-7. Epub 2016 Nov 21.
6
Safety and potential usefulness of sequential intracoronary acetylcholine and ergonovine administration for spasm provocation testing.序贯冠状动脉内乙酰胆碱和麦角新碱给药在痉挛激发试验中的安全性和潜在有用性。
Ther Adv Cardiovasc Dis. 2024 Jan-Dec;18:17539447241233168. doi: 10.1177/17539447241233168.
7
Which Coronary Artery Should Be Preferred for Starting the Coronary Spasm Provocation Test?冠状动脉痉挛激发试验应首选哪支冠状动脉开始?
Life (Basel). 2023 Oct 17;13(10):2072. doi: 10.3390/life13102072.
8
Intracoronary Acetylcholine Provocation Testing - Omission of the 20-µg Dose Is Feasible in Patients Without Coronary Artery Spasm in the Other Coronary Artery.冠状动脉内乙酰胆碱激发试验——在无其他冠状动脉痉挛的患者中可省略20μg剂量。
Circ J. 2016 Jul 25;80(8):1820-3. doi: 10.1253/circj.CJ-16-0344. Epub 2016 Jun 28.
9
New combined spasm provocation test in patients with rest angina: intracoronary injection of acetylcholine after intracoronary administration of ergonovine.静息型心绞痛患者新的联合痉挛激发试验:冠脉内给予麦角新碱后冠脉内注射乙酰胆碱。
Jpn Circ J. 2000 Aug;64(8):559-65. doi: 10.1253/jcj.64.559.
10
Clinical and angiographical characteristics of acetylcholine- induced spasm: relationship to dose of intracoronary injection of acetylcholine.乙酰胆碱诱发痉挛的临床及血管造影特征:与冠状动脉内注射乙酰胆碱剂量的关系。
Coron Artery Dis. 2002 Jun;13(4):231-6. doi: 10.1097/00019501-200206000-00005.

引用本文的文献

1
A Comprehensive Literature Review Discussing Diagnostic Challenges of Prinzmetal or Vasospastic Angina.一篇讨论变异型或血管痉挛性心绞痛诊断挑战的综合文献综述。
Cureus. 2025 May 8;17(5):e83745. doi: 10.7759/cureus.83745. eCollection 2025 May.

本文引用的文献

1
JCS/CVIT/JCC 2023 Guideline Focused Update on Diagnosis and Treatment of Vasospastic Angina (Coronary Spastic Angina) and Coronary Microvascular Dysfunction.《日本循环学会/心血管介入治疗学会/日本心脏病学会2023年血管痉挛性心绞痛(冠状动脉痉挛性心绞痛)和冠状动脉微血管功能障碍诊断与治疗指南重点更新》
Circ J. 2023 May 25;87(6):879-936. doi: 10.1253/circj.CJ-22-0779. Epub 2023 Apr 6.
2
Does the intracoronary pressure differ according to two types (diffuse or focal) of coronary spasm?冠状动脉内压力在冠状动脉痉挛的两种类型(弥漫性或局灶性)之间是否存在差异?
World J Cardiol. 2023 Jan 26;15(1):1-12. doi: 10.4330/wjc.v15.i1.1.
3
Management of vasospastic angina.
血管痉挛性心绞痛的治疗。
Heart. 2022 Dec 13;109(1):70-77. doi: 10.1136/heartjnl-2022-321268.
4
Haemodynamic characterisation of different endotypes in coronary artery vasospasm in reaction to acetylcholine.乙酰胆碱激发下冠状动脉痉挛不同内型的血流动力学特征
Int J Cardiol Heart Vasc. 2022 Aug 13;42:101105. doi: 10.1016/j.ijcha.2022.101105. eCollection 2022 Oct.
5
Coronary Vasospastic Angina: A Review of the Pathogenesis, Diagnosis, and Management.冠状动脉痉挛性心绞痛:发病机制、诊断及管理综述
Life (Basel). 2022 Jul 27;12(8):1124. doi: 10.3390/life12081124.
6
Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard Protocols.乙酰胆碱冠状动脉内激发试验的安全性及其对标准方案的影响。
J Am Coll Cardiol. 2022 Jun 21;79(24):2367-2378. doi: 10.1016/j.jacc.2022.03.385.
7
Serum Potassium Levels of 4.5 to Less Than 5.0 mmol/L Are Associated with Better Vascular Function.血清钾水平为 4.5 至 5.0mmol/L 以下与更好的血管功能相关。
J Atheroscler Thromb. 2022 Nov 1;29(11):1588-1602. doi: 10.5551/jat.63285. Epub 2021 Dec 23.
8
Coronary vasospasm: A narrative review.冠状动脉痉挛:一篇叙述性综述。
World J Cardiol. 2021 Sep 26;13(9):456-463. doi: 10.4330/wjc.v13.i9.456.
9
Principles and pitfalls in coronary vasomotor function testing.冠状动脉血管舒缩功能检测的原则与陷阱。
EuroIntervention. 2022 Feb 18;17(15):1271-1280. doi: 10.4244/EIJ-D-21-00402.
10
Prognostic Links Between OCT-Delineated Coronary Morphologies and Coronary Functional Abnormalities in Patients With INOCA.在INOCA 患者中,OCT 界定的冠状动脉形态与冠状动脉功能异常之间的预后关联。
JACC Cardiovasc Interv. 2021 Mar 22;14(6):606-618. doi: 10.1016/j.jcin.2020.12.025.